Rofaday

Product Overview

Rofaday is a prescription medication formulated with the active ingredient Roflumilast (500mcg) in tablet form. Designed for chronic obstructive pulmonary disease (COPD) management, this phosphodiesterase-4 (PDE4) inhibitor specifically targets lung inflammation associated with COPD. Through its anti-inflammatory action, Rofaday helps enhance respiratory function and decreases the occurrence of COPD flare-ups.

Therapeutic Applications

Rofaday is indicated for severe COPD cases involving chronic bronchitis with a history of exacerbations. Important Note: This medication is not designed for acute symptom relief (such as sudden bronchospasm or asthma attacks) and should never serve as emergency treatment for breathing difficulties. Rofaday functions as one component of a complete COPD treatment regimen, which may incorporate bronchodilators, inhaled corticosteroids, and oxygen therapy.

Administration Guidelines

Take Rofaday tablets orally once daily, maintaining consistency in timing (with or without meals) as prescribed. Swallow tablets whole with water – do not crush, chew, or split them. Strict adherence to the prescribed schedule optimizes therapeutic outcomes. Never adjust dosage without medical consultation.

Mechanism of Action

Rofaday exerts its therapeutic effect through selective inhibition of phosphodiesterase-4 (PDE4), an enzyme involved in pulmonary inflammatory processes. By modulating this pathway, the medication reduces airway inflammation, thereby improving respiratory capacity in COPD patients. This mechanism leads to symptomatic relief (reduced coughing, wheezing, dyspnea) and decreased exacerbation frequency/severity.

Dosage Protocol

Standard dosage: One 500mcg tablet taken orally once daily. Maintain consistent administration timing regardless of meals. Important precautions:
• Never exceed one tablet daily
• If a dose is missed, take when remembered (unless close to next dose)
• Never double dose to compensate for missed administration

Therapeutic Advantages

Key benefits of Rofaday therapy include:

• Anti-inflammatory action with improved pulmonary function
• Reduction in characteristic COPD symptoms (cough, wheeze, dyspnea)
• Decreased exacerbation frequency and intensity
• Convenient once-daily dosing regimen
• Integration potential with comprehensive COPD management plans

Adverse Effects

Commonly reported side effects (typically mild-moderate and transient) include:
• Gastrointestinal disturbances (diarrhea, nausea)
• Cephalalgia (headache)
• Sleep disturbances (insomnia)
• Unintentional weight reduction
Consult your healthcare provider if these persist or intensify.

Important Precautions

Contraindications include hypersensitivity to Roflumilast or formulation components. Exercise caution with severe hepatic impairment. Not indicated for:
• Asthma treatment
• Acute bronchospasm management
• Emergency respiratory distress situations

Storage Requirements

Maintain at controlled room temperature (avoid moisture/heat exposure). Keep securely stored away from children/pets. Discard after expiration date indicated on packaging.

Medical Disclaimer:

While we strive to provide accurate, physician-reviewed information, this content should not replace professional medical advice. The presented information serves educational purposes only and may not encompass all potential drug interactions, contraindications, or adverse effects. Always consult your healthcare provider regarding medical conditions and treatments. Our purpose is to supplement, not substitute, the crucial physician-patient relationship.